Diet and exercise may fight frailty in prostate cancer survivors

NCT ID NCT03880422

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 32 times

Summary

This study tests whether personalized nutrition and exercise plans can reduce frailty and improve body composition in prostate cancer survivors who are on hormone therapy (ADT). Fifty participants will receive diet advice, exercise coaching, and educational sessions. Researchers will measure changes in muscle mass, fat, strength, and mobility over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Roswell Park Cancer Institute

    RECRUITING

    Buffalo, New York, 14263, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

dietary plan, exercise program, and educational sessions

What this could lead to

If successful, this could show that personalized nutrition and exercise help prostate cancer patients feel stronger, reduce frailty, and improve body composition during hormone therapy.

What could go wrong

This is a small early-phase study (50 people) with no control group, so results may not apply broadly. Benefits may be modest or not sustained.

Conditions

The condition(s) this trial relates to.

metastatic prostate carcinoma Obesity obesity disorder Overweight prostate adenocarcinoma prostate cancer prostate carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.